As of November 6, 2026, LENSAR, Inc. is a publicly traded company (Nasdaq: LNSR); its largest reported holder is Brandes Investment Partners, LP, with 8.5% on Schedule 13G/A of May 14, 2026. The largest insider holding is Thomas B. Ellis, a director and 10% owner, with 1,156,675 shares (9.4% of shares outstanding), per Form 4 of June 5, 2026 (Schedule 13G/A, May 14, 2026).
Is this your company?
About to sign with, pay or invest in LENSAR, Inc.? See the free Snapshot first.
Free to see. No signup.
Is LENSAR, Inc. a real, registered company?
- LENSAR, Inc. files with the SEC under CIK 1320350 (its SEC filings).
- Its shares are listed under the ticker LNSR on Nasdaq (SEC company record).
- Incorporated in Delaware; business address in Orlando, Florida, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under LENSAR, Inc. in our court records and SEC 8-K records (as of 2026-11-06).
- Leadership changes: the latest reported is Michael A. Rossi, Chief Financial Officer (Form 8-K filed 2026-05-29). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Brandes Investment Partners, LP (filed 2026-05-14).
Who are LENSAR, Inc.'s owners and officers?
LENSAR, Inc.: incorporated in Delaware; business address in Orlando, Florida; industry Surgical & Medical Instruments & Apparatus (Schedule 13G/A, 2026-07-29).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2023-05-26)
- : Executive Officer (Form D, 2023-05-26)
- : Executive Officer (Form D, 2023-05-26)
- : Director (Form D, 2023-05-26)
- : Director (Form D, 2023-05-26)
- : Director (Form D, 2023-05-26)
- : Director (Form D, 2023-05-26)
- : Director (Form D, 2023-05-26)
- : Director (Form D, 2023-05-26)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G/A, 2026-07-29 | Blackrock, Inc. | 1.5% |
| Schedule 13G/A, 2026-05-14 | Brandes Investment Partners, LP | 8.5% |
| Schedule 13G, 2025-11-13 | Brandes Investment Partners, LP | 6.5% |
| Schedule 13G, 2025-10-17 | Blackrock, Inc. | 5.2% |
Questions about who owns LENSAR, Inc.
Who owns LENSAR, Inc.?
On this page, one holder's latest ownership filing reports 5% or more of LENSAR, Inc.: Brandes Investment Partners, LP (8.5%, Schedule 13G/A, filed 2026-05-14).
When did Brandes Investment Partners, LP buy into LENSAR, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Brandes Investment Partners, LP on this page is the Schedule 13G, filed 2025-11-13, reporting 6.5%; its latest, Schedule 13G/A filed 2026-05-14, reports 8.5%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on LENSAR, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on LENSAR, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on LENSAR, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
13 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-05-29 | Michael A. Rossi | Chief Financial Officer | appointed | 2026-05-29 |
| Form 8-K, 2026-04-15 | Thomas R. Staab | Chief Financial Officer | departed | 2026-05-08 |
Which insiders own LENSAR, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a director and 10% owner: 1,156,675 shares (9.4% of shares outstanding), 56,083 held directly and 1,100,592 indirectly (Form 4, 2026-06-05).
- , a director and 10% owner: 1,156,675 shares (9.4% of shares outstanding), 56,083 held directly and 1,100,592 indirectly (Form 4, 2026-06-05).
- , the chief executive and a director: 1,122,758 shares (9.1% of shares outstanding) (Form 4, 2026-06-05).
- , a director: 568,062 shares (4.6% of shares outstanding) (Form 4, 2026-06-05).
- , the chief operating officer: 389,173 shares (3.2% of shares outstanding) (Form 4, 2026-06-05).
Shares outstanding: 12,285,865 as of 2026-07-31, from the company's latest SEC cover page.
How much has LENSAR, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2023-05-26 | $20M | $20M |
Keep reading
More on LENSAR, Inc. and the records around it.
LENSAR, Inc. elsewhere on the record
- Leadership changes May 2026
Companies that share a holder
- BRANDES INVESTMENT PARTNERS, LP also filed stake reports on 26 other companies: Globant S.A. (Oct 2026), American Outdoor Brands, Inc. (Aug 2026), HURCO COMPANIES INC (Aug 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/lensar